An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A small app called Peptide Tracker has started a “Founding Member” program that lets users support the project without locking features behind a paywall. In plain terms, the team is asking people to contribute money if they want to help keep the app running and improve it, but they’re saying the core parts of the app will stay free for everyone. Peptide Tracker is an app for people who follow peptide treatments and research. “Peptides” are short chains of amino acids — think of them as tiny versions of the proteins your body uses to send signals or do jobs. The app helps users track doses, side effects, and research news around various peptide-based therapies or supplements. It’s not a drug company; it’s a tool for people who are managing or learning about peptide-related treatments. What the announcement shows is mostly about the app’s business model, not a scientific claim. The founders announced a membership tier called Founding Member that gives supporters recognition and maybe some extra conveniences. They emphasized that basic tracking and information will remain free and that this is a voluntary way to fund development. There’s no new clinical data, no changes in medical advice, and no claim that the membership affects safety or effectiveness of any peptide treatments. Why this matters is practical: tools that help people track medications and side effects can be genuinely useful, especially for treatments with complex dosing or off-label uses. If Peptide Tracker can sustain itself through voluntary support rather than putting key features behind a paywall, more people can keep using it without financial barriers. That could help patients, caregivers, and hobbyist followers stay organized and better communicate with their clinicians. Caveats and risks: this is a funding/business move, not a medical endorsement. The app’s accuracy and privacy protections matter a lot—users should check how their health data is stored and shared. Also, an app is only as good as the information behind it; it doesn’t replace medical advice. If you’re using peptides prescribed by a doctor, keep following clinical guidance. If you’re experimenting on your own, remember that many peptide uses are unregulated or off-label and carry unknown risks. Bottom line: Peptide Tracker is offering voluntary paid memberships to help fund the app while promising to keep basic features free—useful if you want a tracking tool, but not a substitute for medical care.
Source: Lelezard